Bextra Articles

San Francisco, CA: Joann Simmons is a name on a court docket now—just two words in a legal document. But those two words represent someone's life partner, who is no longer here. And the life partner left behind, James Simmons, has filed a wrongful death suit against the makers of Bextra.

Tulsa, OK: Jay Sullivan is a cancer survivor, which is an accomplishment in itself. He's also a survivor of Merck's Vioxx and Pfizer's Bextra, two nonsteroidal anti-inflammatory drugs (NSAIDS) that were pulled from the market because of a dangerously high risk of heart attack.

San Francisco, CA: Nearly four years after Bextra was taken off the market for cardiovascular risk, the first Bextra trial is scheduled to be heard May 5th. On the heels of the mammoth $4.85 billion Vioxx settlement, the Multi-District Litigation (MDL) Court for the Bextra/Celebrex litigation is finally ramping up in California.

Atlanta, GA: "I was told that if my mother had lived--as a vegetable in a hospital bed-- there would be a lawsuit, but because she died, there was no recourse," says Dianne Nev. "Pfizer, the maker of Bextra, can't make you a vegetable and get away with it, but they can get away with murder."